A comprehensive bioinformatics analysis of pathways and biomarkers shared between type 2 diabetes mellitus and chronic obstructive pulmonary disease
The T-cell pathway may be involved in the pathogenesis of T2DM and COPD, and SUMF2 may be a potential diagnostic marker, and its high expression in T-cell subsets suggests a possible role in the immunomodulatory mechanisms underlying the two diseases.
Authors
- Min Jiang (ORCID: https://orcid.org/0000-0003-1345-9227)
- Dan Xu (ORCID: https://orcid.org/0000-0001-6649-1111)
- Jianbing Ding (ORCID: https://orcid.org/0000-0001-5506-7665)
- Duan Xiao-mei
- Fengsen Li (ORCID: https://orcid.org/0000-0002-8012-3769)
- Tingting Hu (ORCID: https://orcid.org/0000-0002-2058-2664)
- Jing Wang (ORCID: https://orcid.org/0000-0002-6142-7628)
- Zheng Li (ORCID: https://orcid.org/0000-0002-2882-6600)
- Li Ma (ORCID: https://orcid.org/0000-0002-2375-6674)
- Jiale Gao (ORCID: https://orcid.org/0000-0002-6992-7387)
- Jing Jing
Institutions
- Xinjiang Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-07-25
- DOI
- https://doi.org/10.3389/fimmu.2025.1536551
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Xinjiang